Follow
Richard G. Abramson, MD, MHCDS, FACR
Richard G. Abramson, MD, MHCDS, FACR
Biomedical Engineering, Vanderbilt University
No verified email
Title
Cited by
Cited by
Year
Synseg-net: Synthetic segmentation without target modality ground truth
Y Huo, Z Xu, H Moon, S Bao, A Assad, TK Moyo, MR Savona, ...
IEEE transactions on medical imaging 38 (4), 1016-1025, 2018
2352018
Adversarial synthesis learning enables segmentation without target modality ground truth
Y Huo, Z Xu, S Bao, A Assad, RG Abramson, BA Landman
2018 IEEE 15th international symposium on biomedical imaging (ISBI 2018 …, 2018
1632018
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer
X Li, RG Abramson, LR Arlinghaus, H Kang, AB Chakravarthy, ...
Investigative radiology 50 (4), 195-204, 2015
1592015
Evaluation of six registration methods for the human abdomen on clinically acquired CT
Z Xu, CP Lee, MP Heinrich, M Modat, D Rueckert, S Ourselin, ...
IEEE Transactions on Biomedical Engineering 63 (8), 1563-1572, 2016
1552016
DCE‐MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings
X Li, LR Arlinghaus, GD Ayers, AB Chakravarthy, RG Abramson, ...
Magnetic resonance in medicine 71 (4), 1592-1602, 2014
1482014
Medical image computing and computer-assisted intervention—MICCAI 2016
Z Xu, AJ Asman, PL Shanahan, RG Abramson, BA Landman
Springer, 2016
1262016
Quantitative multimodality imaging in cancer research and therapy
TE Yankeelov, RG Abramson, CC Quarles
Nature Reviews Clinical Oncology 11 (11), 670-680, 2014
1232014
Methods and challenges in quantitative imaging biomarker development
RG Abramson, KR Burton, JY John-Paul, EM Scalzetti, TE Yankeelov, ...
Academic radiology 22 (1), 25-32, 2015
1112015
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
BD Lehmann, VG Abramson, ME Sanders, EL Mayer, TC Haddad, ...
Clinical Cancer Research 26 (9), 2111-2123, 2020
1082020
Efficient multi-atlas abdominal segmentation on clinically acquired CT with SIMPLE context learning
Z Xu, RP Burke, CP Lee, RB Baucom, BK Poulose, RG Abramson, ...
Medical image analysis 24 (1), 18-27, 2015
1082015
Clinical utility of quantitative imaging
AB Rosenkrantz, M Mendiratta-Lala, BJ Bartholmai, D Ganeshan, ...
Academic radiology 22 (1), 33-49, 2015
1082015
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results
RG Abramson, X Li, TL Hoyt, PF Su, LR Arlinghaus, KJ Wilson, ...
Magnetic resonance imaging 31 (9), 1457-1464, 2013
1022013
The impact of arterial input function determination variations on prostate dynamic contrast-enhanced magnetic resonance imaging pharmacokinetic modeling: a multicenter data …
W Huang, Y Chen, A Fedorov, X Li, GH Jajamovich, DI Malyarenko, ...
Tomography 2 (1), 56-66, 2016
932016
VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4
SD Kost, YK Dewaraja, RG Abramson, MG Stabin
Cancer Biotherapy and Radiopharmaceuticals 30 (1), 16-26, 2015
892015
Simultaneous PET–MRI in oncology: a solution looking for a problem?
TE Yankeelov, TE Peterson, RG Abramson, D Garcia-Izquierdo, ...
Magnetic resonance imaging 30 (9), 1342-1356, 2012
862012
Fully convolutional neural networks improve abdominal organ segmentation
MF Bobo, S Bao, Y Huo, Y Yao, J Virostko, AJ Plassard, I Lyu, A Assad, ...
Medical Imaging 2018: Image Processing 10574, 750-757, 2018
832018
Tutor versus computer: a prospective comparison of interactive tutorial and computer-assisted instruction in radiology education
G Lieberman, R Abramson, K Volkan, PJ McArdle
Academic Radiology 9 (1), 40-49, 2002
692002
IEEE 15th international symposium on biomedical imaging (ISBI 2018)
Y Huo, Z Xu, S Bao, A Assad, RG Abramson, BA Landman
Piscataway: IEEE, 1217-1220, 2018
682018
Overview of targeted therapies for cancer
R Abramson
My cancer genome, 2016
632016
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer
E Chan, LR Arlinghaus, DB Cardin, L Goff, JD Berlin, A Parikh, ...
Radiotherapy and Oncology 119 (2), 312-318, 2016
562016
The system can't perform the operation now. Try again later.
Articles 1–20